Genedata Biologics Partner Symposium 2021
Tuesday, April 13, 2021 |
---|
Pre-Symposium Poster Session (Session repeated at end of day) |
Opening Remarks Othmar Pfannes, CEO, Genedata, Basel, Switzerland Jana Hersch, Scientific Consultant, Genedata, Basel, Switzerland |
Keynote – Pfizer’s New Gene Therapy Workflows – AAVs and Beyond Joel Bard, Associate Research Fellow, BioMedicine Design, Pfizer, Cambridge, MA, USA |
Clone Batch Customizations in Genedata Biologics enabling New Automation Platforms at GSK Daniel Badcock, Scientific Leader, High Throughput Antibody Expression and Purification, GSK Medicines Research Centre, Stevenage, UK |
Janssen's High-Throughput Biopharma R&D in the Digital Age John Boles, Business Technology Leader, Janssen, Spring House, PA, USA Siva Sakkiahpandy, Project Manager, Janssen, Spring House, PA, USA Kim Munsell, Senior Computer System Validation and Compliance Manager, Janssen, Spring House, PA, USA |
Virtual Coffee Break @ the Genedata Cafe |
BI’s Data Review Center – Optimizing Checks and Balances for Biophysical Data Entry into Genedata Biologics Samuel Cheng, IS Lead Business Consultant, IT RDM Research, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA Tadas Panavas, Senior Principal Scientist, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA |
Genedata Biologics @ Novartis – Pushing the Limits Björn Hüber, Team Leader Data Management, Novartis - NIBR Biologics Center, Basel, Switzerland Desmond Fox, NX Business Analyst, Novartis - NIBR Biologics Center, Basel, Switzerland |
Biologics Update & Roadmap: Automation, Cell and Gene Therapies, and Other Innovations Guido Cappuccilli, Product Manager, Genedata, Basel, Switzerland |
Closing Remarks |
Post-Symposium Poster Session (Repeat of Pre-Symposium Session) |
Wednesday, April 14, 2021 |
---|
Pre-Symposium Demo Session (Session repeated at end of day) |
Opening Remarks Jessy Sheng, Scientific Consultant, Genedata, San Francisco, CA, USA |
Keynote – Janssen's Biotherapeutic Workflows – Multispecifics, CAR-Ts and More Patrick Doonan, Principal Scientist, Janssen, Spring House, PA, USA Ninkka Tamot, Scientist, Janssen, Spring House, PA, USA |
TCER® Development at Immatics and Deployment of Genedata Felix Unverdorben, Associate Director Immunology, Immatics Biotechnologies, Tübingen, Germany |
Building onto Genedata Biologics – Integration Backbone for Sanofi’s R&D IT Infrastructure Jay Randazzo, Digital Service Owner – Large Molecule Research, Sanofi, Cambridge, MA, USA Joachim Meyer, IT Solution Expert Biologics, Sanofi, Frankfurt am Main, Germany |
Virtual Coffee Break @ the Genedata Cafe |
Panel Discussion – Cell & Gene Therapy Trends, Challenges & Bottlenecks Joel Bard, Associate Research Fellow, BioMedicine Design, Pfizer, Cambridge, MA, USA Ninkka Tamot, Scientist, Janssen, Spring House, PA, USA Hugo de Wit, Head of Advanced Therapies, Sartorius, Ulm, Germany |
Streamlining Cell Line Development Processes at Sartorius – Increasing Productivity by a Factor of Three Hugo de Wit, Head of Advanced Therapies, Sartorius, Ulm, Germany |
Genedata Biologics & Bioprocess Deployment at Octapharma: From Lead Discovery to Formulation Christoph Schanzenbächer, Scientist, Recombinant Research and Development, Octapharma Biopharmaceuticals GmbH, Heidelberg, Germany |
Genedata Bioprocess Update & Roadmap: CLD, USP, DSP, Formulation and Analytical Development Yang-Chieh Chou, Product Manager, Genedata, Basel, Switzerland |
Closing Remarks |
Post-Symposium Demo Session (Repeat of Pre-Symposium Session) |
Thursday, April 15, 2021 |
---|
Pre-Symposium Virtual Coffee Break @ the Genedata Cafe |
Opening Remarks Adrienne Craig-Kennard, Head of Biologics Sales, US, Genedata, San Francisco, CA, USA |
Connecting Biotherapeutics Across Two Heritage Companies: Our Journey to Extend Genedata Use at BMS Lore Florin, Director Antibody Generation, Bristol Myers Squibb, Redwood City, CA, USA |
Integrating Biologics with Merck’s R&D Data Systems Sameh Eid, Principal Scientist, Research Informatics, Merck Healthcare KGaA, Darmstadt, Germany Erin Williams, Associate Lab Head / Scientific Manager, Quality Control, EMD Serono, Billerica, MA, USA |
Panel Discussion – Digitalization in Biopharma R&D: Where are we Now and Where are we Going? Yuan Lin, Biologics Business Partner, Pfizer, Cambridge, MA, USA Przemek Stasica, Biopharm Discovery Data Designer, GSK, Medicines Research Centre, Stevenage, MA, USA Uwe Wittenberg, Director Research Informatics, Merck Healthcare, Darmstadt, Germany Lore Florin, Director Antibody Generation, Bristol Myers Squibb, Redwood City, CA, USA Tristan Magnay, Digital Biologics Platform Site Lead, US, Sanofi, Framingham, MA, USA Karsten Thierbach, Group Manager R&D Purification and Analytics III, Octapharma, Heidelberg, Germany Markus Sanna, Manager Digital Data Excellence and IT Services, Sartorius Stedim Cellca GmbH, Ulm, Germany |
Virtual Coffee Break @ the Genedata Cafe |
Using Genedata Biologics to Improve Biotherapeutic Decisions at Pfizer Joseph DeBartolo, Senior Principal Scientist, BioMedicine Design, Pfizer, Cambridge, MA, USA |
Sanofi's PEPP System and Genedata Biologics – High-Throughput Mid-Scale Production of Multi-Format Proteins Tristan Magnay, Digital Biologics Platform Site Lead, US, Sanofi, Framingham, MA, USA |
Genedata Architecture 2021 Initiative Sebastian Schlicker, Head of Operations, Genedata, Basel, Switzerland |
Closing Remarks |
Post-Symposium Virtual Coffee Break @ the Genedata Cafe |
End of Symposium |
Back